Mycoses

Article	Citations
Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia	201
Development of single‐tube real‐time PCR assay for the rapid detection of Aspergillus and Fusarium—The two most common causative agents in fungal keratitis	157
Physicians' knowledge of invasive fungal disease in China	129
Author Index	110
Intra‐Abdominal Candidiasis in Cancer Patients: A 10‐Year Experience in a Middle‐Income Country	83
	82
State of Medical Mycology at German Academic Medical Centres: A Survey of the German‐Speaking Mycological Society (DMYKG) and the Paul‐Ehrlich‐Society for Chemotherapy (PEG)	53
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non‐fumigatus): A multicentre, non‐interventional regist	47
Low toxicity contributes to Sporothrix globosa invade the skin of patients in low‐epidemic areas of China	46
High attenuation mucus in bronchi with allergic bronchopulmonary mycosis	44
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia	43
Emergence of Candida auris in intensive care units in Algeria	40
Multicenter Candida auris outbreak caused by azole‐susceptible clade IV in Pernambuco, Brazil	38
Global Insights and Trends in Research on Dermatophytes and Dermatophytosis: A Bibliometric Analysis	38
Review Article White Piedra: Review of 131 cases	37
Issue Information	37
Performance of the IMMY® sona Aspergillus lateral flow assay for the detection of galactomannan in tracheal aspirate samples from Brazilian patients with COVID‐19‐associat	37
Combined ImmunoCAP and Western Blot for the Diagnosis of Aspergillus Lung Disease	37
Global epidemiological burden of fungal infections in cirrhosis patients: A systematic review with meta‐analysis	33
Diverse Colonisation and Disease Associations of the Human Commensal Malassezia: Our Body's Secret Tenant	32
T‐cell dysfunction as a potential contributing factor in post‐COVID‐19 mucormycosis	31
Changing demographics and risk factors for cryptococcosis: A 12‐year review at a tertiary care centre	30
Issue Information	30
Pan‐azole‐resistant Meyerozyma guilliermondii clonal isolates harbouring a double F126L and L505F mutation in Erg11	29
Issue Information	29

Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non‐psoriatic patients: A prospective study	26
Active screening of COVID‐19‐associated pulmonary aspergillosis with serum beta‐glucan and endotracheal aspirates galactomannan and fungal culture	26
Species distribution, azole resistance and related molecular mechanisms in invasive Candida parapsilosis complex isolates: Increase in fluconazole resistance in 21 years	26
Prototype early diagnostic model for invasive pulmonary aspergillosis based on deep learning and big data training	26
Combination therapy with itraconazole and terbinafine for phaeohyphomycosis caused by Exophiala spinifera: A case report and literature review	26
The Paediatric European Confederation of Medical Mycology (ECMM) Quality (Paed‐EQUAL) Candida Score for the Management of Candidaemia in Children and Neonates	25
Corrections to “Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study”	25
Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil	25
A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic	25
Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis	24
Optimization of a commercial Histoplasma galactomannan EIA test in a population from an endemic area of histoplasmosis in southern Brazil	24
Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole	24
Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment	23
Cover Image	23
Comparative Analysis of Chemiluminescence Immunoassay (CLIA)‐Based Tests in the Diagnosis of Invasive Aspergillosis in Patients With Hematologic Malignancies	22
Machine‐learning‐based virtual screening to repurpose drugs for treatment of Candida albicans infection	22
Issue Information	21
Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum‐equiseti species complexes from onychomycosis in north of I	21
Tinea pedis in underrepresented groups: All of Us database analysis	21
Comparative analysis of galactomannan lateral flow assay, galactomannan enzyme immunoassay and BAL culture for diagnosis of COVID‐19‐associated pulmonary aspergillosis	20
Performance of the RealStar®Pneumocystis jirovecii PCR kit for the diagnosis of Pneumocystis pneumonia	20
	20
Aspergillus‐PCR in bronchoalveolar lavage ‐ diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients	20
Diagnostic performance of noncultural methods for central nervous system aspergillosis	20
CARD9 mutations in patients with fungal infections: An update from the last 5 years	20
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single‐centre experience in Iran	20
	19
How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species?	19
	18
Expression of epidermal antimicrobial peptides is increased in tinea pedis	18
Screening Candida auris through a multiplex stepwise PCR algorithm directly from clinical samples of patients suspected of otomycosis in south of Iran; Detection of five cases	18
	18
Fungaemia due to rare yeasts in paediatric intensive care units: A prospective study	17
	17
Histoplasma antigen detection in unconfirmed pulmonary tuberculosis and cross‐reactivity with Aspergillus antigen in patients and in food in Jakarta, Indonesia	17
Immune reconstitution inflammatory syndrome in non‐HIV cryptococcal meningitis: Cross‐talk between pathogen and host	17
Gradient diffusion strips for detecting azole resistance in Aspergillus fumigatus sensu lato	17
Chronic pulmonary aspergillosis in patients with active pulmonary tuberculosis with persisting symptoms in Uganda	16
Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases	16
Treatment of the Candida subspecies Candida albicans and Candida parapsilosis with two far‐UVC sources to minimise mycoses in clinical practice	16
Performance of existing clinical scores and laboratory tests for the diagnosis of invasive candidiasis in critically ill, nonneutropenic, adult patients: A systematic review with qualitative evidence	16
Challenges towards management of CARD9‐deficient patients with phaeohyphomycosis: A case report and case series study	16
Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease	16
Azole resistance in Aspergillus fumigatus. The first 2‐year's Data from the Danish National Surveillance Study, 2018–2020	15
Chinese expert consensus on management of antifungal‐resistant dermatophytoses (2024 edition)	15
Subtilisin 6 From the Dermatophyte Trichophyton benhamiae Is a Marker of Infection but Not a Unique Virulence Factor	15
Epidemiological patterns of candidaemia: A comprehensive analysis over a decade	15
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐ and middle‐income countries	15
EQUAL ABPA Score 2024: A Tool to Measure Guideline Adherence for Managing Allergic Bronchopulmonary Aspergillosis	15
Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients	14

Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain	14
Application of machine learning for mortality prediction in patients with candidemia: Feasibility verification and comparison with clinical severity scores	14
Modified Tinea Corporis Score (mTCS) Versus Tinea Corporis Score (TCS): A Comparative, Noninterventional Validation Study	14
Evaluation of the Post‐Antifungal Effect of Rezafungin and Micafungin against Candida albicans, Candida parapsilosis and Candida glabrata	14
	14
A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India	14
Issue Information	14
Dermatophytosis and the associated risk factors among primary school children in southern and central Côte d'Ivoire	14
Multimodal analysis of the COVID‐19‐associated mucormycosis outbreak in Delhi, India indicates the convergence of clinical and environmental risk factors	14
Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment	13
	13
Revisiting the pathogenesis of dermatophytosis: A cross‐sectional analytic study of serum levels of interleukins‐2, 8, 10 and 17	13
Virulence of Candida spp. Isolates From Patients With Recurrent Vulvovaginal Candidosis Is Associated With the Number of Episodes	13
Lower beta‐1,3‐D‐glucan testing cut‐offs increase sensitivity for non‐albicans Candida species bloodstream infections	13
Effect of volume of instillate on the diagnostic utility of bronchoalveolar lavage galactomannan in patients with suspected chronic pulmonary aspergillosis—A pilot study	12
	12
The In Vitro Activity of Rezafungin Against Uncommon Species of Candida	12
Isolated tracheobronchial mucormycosis: Report of a case and systematic review of literature	12
Epidemiology of Vulvovaginal Candidiasis in Greece: A 2‐Year Single‐Centre Study	12
Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis—A Six‐year Retrospective Cohort Study	12
Morphological and genetic identification of fungal genus/species in formalin‐fixed, paraffin‐embedded specimens obtained from patients with histologically proven fungal infection	12
A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections	12
	12
Issue Information	11
Posters	11
Frequency and causes of antifungal treatment changes in allogeneic haematopoïetic cell transplant recipients with invasive mould infections	11
	11
Clinico‐mycological validation of dermatophytosis severity score and its correlation with patient‐reported outcome measures	11
Correction to Nd:YAG 1064 nm laser treatment for onychomycosis—Is it really effective? A prospective assessment for efficiency and factors contributing to response	11
When and how do we stop antifungal treatment for an invasive mould infection in allogeneic haematopoietic cell transplant recipients?	11
Tropicoporus tropicalis: A Newly Recognised Pathogen in Eumycetoma and Refractory Mycoses in Humans	10
Clinical Significance of Aspergillus Sensitisation in Chronic Pulmonary Aspergillosis	10
Fungal Disease Response Centre: Pioneering Diagnostic Approach for Regions With Dispersed Hospital Centres	10
Vaginal microbiota in pregnant women with inflammatory rheumatic and inflammatory bowel disease: A matched case‐control study	10
Morbidity and mortality of hospitalised patients with candidemia during the various severe acute respiratory syndrome coronavirus 2 pandemic waves: A multicentre evaluation of 248 US hospit	10
Expert recommendations for prevention and management of Candida auris transmission	10
Clinical characteristics and risk factors for late‐onset pneumocystis jirovecii pneumonia in kidney transplantation recipients	10
Cryptococcosis in the Democratic Republic of Congo from 1953 to 2021: A systematic review and meta‐analysis	10
Aspergillus nodules: Natural history and the effect of antifungals	10
Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study	10
Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?	10
	10
Saksenaea vasiformis infection: Extensive abdominal wall necrotizing fasciitis with systematic review and analysis of 65 cases	9
Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases	9
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID‐19–associated mucormycosis in a real‐life setting	9
Secondary invasive fungal infection in hospitalised patients with COVID‐19 in the United States	9
A retrospective Italian analysis on the characteristics of invasive fungal infections in the intensive care unit setting: CHARTER‐IFI study	9
Retrospective Epidemiology of Dermatomycosis in Kinshasa, Democratic Republic of Congo, From 2000 to 2023	9
Updated estimation of the burden of fungal disease in Vietnam	9
Usefulness of 18F‐FDG PET‐CT for the management of invasive fungal infections: A retrospective cohort from a tertiary university hospital	9
Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients	9
Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis	9
Current situation of endemic mycosis in the Americas and the Caribbean: Proceedings of the first international meeting on endemic mycoses of the Americas (IMEMA)	9
Epidemiological analysis of nail aspergillosis and non‐dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France	9
Candida albicans skin infection in diabetic patients: An updated review of pathogenesis and management	9
Risk factors for pulmonary mucormycosis in subjects with diabetes mellitus—A case‐control study	9
As the virus sowed, the fungus reaped! A comparative analysis of the clinico‐epidemiological characteristics of rhino‐orbital mucormycosis before and during COVID‐19 pandemic	9
Coccidioidomycosis in Oklahoma: A retrospective case series	9
Abstracts	8
Inter‐observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases	8
A New Medium That Promotes Mass Sporulation of Trichophyton rubrum In Vitro	8
Diagnosis of fungal opportunistic infections in people living with HIV from Guatemala and El Salvador	8
Sensitivity and Specificity of Plasma and Bronchoalveolar Lavage Fluid PCR for Diagnosing Pulmonary Mucormycosis in Subjects With Diabetes Mellitus	8
Candida Infective Endocarditis in Patients With Candida spp. Bloodstream Infection: Risk Factors and 1‐ Year Mortality	8
Issue Information	8
Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation	8
Let's talk about sex characteristics—As a risk factor for invasive fungal diseases	8
Serious fungal disease incidence and prevalence in Indonesia	8
Global, regional, and national burden of fungal skin diseases in 204 countries and territories from 1990 to 2021: An analysis of the global burden of disease study 2021	8
Paediatric cutaneous mucormycosis: A case report and review of the literature	8
Mucormycosis in Africa: Epidemiology, diagnosis and treatment outcomes	8
Mechanism of azole resistance in Candida vulturna, an emerging multidrug resistant pathogen related with Candida haeumulonii and Candida auris	8
Time and cost‐efficient identification of Trichophyton indotineae	8
Exploring the intersection of Aspergillus fumigatus biofilms, infections, immune response and antifungal resistance	8
Multicentre Study of Candida parapsilosis Blood Isolates in Türkiye Highlights an Increasing Rate of Fluconazole Resistance and Emergence of Echinocandin and Multidrug Resistance	7
A clinicoepidemiological study on tinea incognita with assessment of its treatment strategies and drug prescribing practices in a tertiary care hospital	7
An open‐label non‐inferiority randomised control trial comparing nebulised amphotericin B with oral itraconazole in patients with pulmonary aspergilloma	7
Altered skin fungal and bacterial community compositions in tinea capitis	7
Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis	7
Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum	7

Incidence of invasive fungal diseases in inflammatory bowel disease patients: A nationwide study in South Korea	7
The prognostic factors for cryptococcal meningitis in non‐human immunodeficiency virus patients: An observational study using nationwide database	7
Molecular genotyping of Candidaalbicans isolated from different sites may trace the etiological infection routes: Observation in China	7
Real‐world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies	7
A simple high‐volume culture technique—Good substitute for polymerase chain reaction for the detection of Aspergillus species in bronchoalveolar lavage samples	7
Anti‐fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta‐analysis	7
First Reported Cases of Terbinafine‐Resistant Trichophyton indotineae Isolates in Israel: Epidemiology, Clinical Characteristics and Response to Treatment	7
Issue Information	7
Invasive fungal infections in acute and chronic liver impairment: A systematic review	7
	7
Issue Information	7
	7